This document is a summary of the concepts and definitions in the revised area. The changes are, for the most part, related to the theoretical component of the indicator. Data collection recommendations will remain mostly unchanged, with two exceptions: the addition of intensive cannabis use data collection based on general population surveys methodology; and making provision for interested countries to report on other — including new — drugs.
Download as PDF
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.